[Federal Register Volume 75, Number 81 (Wednesday, April 28, 2010)]
[Rules and Regulations]
[Pages 22252-22256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9741]



40 CFR Part 180

[EPA-HQ-OPP-2008-0866; FRL-8801-6]

Cyromazine; Pesticide Tolerances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.


SUMMARY: This regulation establishes tolerances for residues of 
cyromazine in or on succulent beans at 2.0 parts per million (ppm). 
Interregional Research Project Number 4 (IR-4) requested these 
tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA).

DATES: This regulation is effective April 28, 2010. Objections and 
requests for hearings must be received on or before June 28, 2010, and 
must be filed in accordance with the instructions provided in 40 CFR 
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: EPA has established a docket for this action under docket 
identification (ID) number EPA-HQ-OPP-2008-0866. All documents in the 
docket are listed in the docket index available at http://www.regulations.gov. Although listed in the index, some information is 
not publicly available, e.g., Confidential Business Information (CBI) 
or other information whose disclosure is restricted by statute. Certain 
other material, such as copyrighted material, is not placed on the 
Internet and will be publicly available only in hard copy form. 
Publicly available docket materials are available in the electronic 
docket at http://www.regulations.gov, or, if only available in hard 
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac 
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The Docket 
Facility is open from 8:30 a.m. to 4 p.m., Monday through Friday, 
excluding legal holidays. The Docket Facility telephone number is (703) 

FOR FURTHER INFORMATION CONTACT: Barbara Madden, Registration Division, 
Office of Pesticide Programs, Environmental Protection Agency, 1200 
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: 
(703) 305-6463; e-mail address: madden.barbara@epa.gov.


I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
Potentially affected entities may include, but are not limited to those 
engaged in the following activities:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).
    This listing is not intended to be exhaustive, but rather to 
provide a guide for readers regarding entities likely to be affected by 
this action. Other types of entities not listed in this unit could also 
be affected. The North American Industrial Classification System 
(NAICS) codes have been provided to assist you and others in 
determining whether this action might apply to certain entities. If you 
have any questions regarding the applicability of this action to a 
particular entity, consult the person listed under FOR FURTHER 

B. How Can I Access Electronic Copies of this Document?

    In addition to accessing electronically available documents at 
http://www.regulations.gov, you may access this Federal Register 
document electronically through the EPA Internet under the ``Federal 
Register'' listings at http://www.epa.gov/fedrgstr. You may also access 
a frequently updated electronic version of EPA's tolerance regulations 
at 40 CFR part 180 through the Government Printing Office's e-CFR cite 
at http://www.gpoaccess.gov/ecfr.
    To access the OPPTS harmonized test guidelines referenced in this 
document electronically please go to http://www.epa.gov/oppts and 
select ``Test Methods & Guidelines'' on the left-side navigation menu.

[[Page 22253]]

C. Can I File an Objection or Hearing Request?

    Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file 
an objection to any aspect of this regulation and may also request a 
hearing on those objections. You must file your objection or request a 
hearing on this regulation in accordance with the instructions provided 
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify 
docket ID number EPA-HQ-OPP-2009-0866 in the subject line on the first 
page of your submission. All requests must be in writing, and must be 
mailed or delivered to the Hearing Clerk as required by 40 CFR part 178 
on or before June 28, 2010.
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing that does not contain any CBI for inclusion in the public 
docket that is described in ADDRESSES. Information not marked 
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA 
without prior notice. Submit this copy, identified by docket ID number 
EPA-HQ-OPP-2008-0866, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public 
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania 
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P), 
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South 
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only 
accepted during the Docket Facility's normal hours of operation (8:30 
a.m. to 4 p.m., Monday through Friday, excluding legal holidays). 
Special arrangements should be made for deliveries of boxed 
information. The Docket Facility telephone number is (703) 305-5805.

II. Petition for Tolerance

    In the Federal Register of April 13, 2009 (74 FR 16866) (FRL-8396-
6), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21 
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 
8E7470) by Interregional Research Project Number 4 (IR-4), 500 College 
Road East, Suite 201 W, Princeton, NJ 08540. The petition requested 
that 40 CFR 180.414 be amended by establishing tolerances for residues 
of the insecticide cyromazine, (N-cyclopropyl-1,3,5-triazine-2,4,6-
triamine) in or on bean, succulent at 2.0 parts per million (ppm). That 
notice referenced a summary of the petition prepared by Syngenta, the 
registrant, on behalf of IR-4 which is available to the public in the 
docket, http://www.regulations.gov. There were no comments received in 
response to the notice of filing.

III. Aggregate Risk Assessment and Determination of Safety

    Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a 
tolerance (the legal limit for a pesticide chemical residue in or on a 
food) only if EPA determines that the tolerance is ``safe.'' Section 
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a 
reasonable certainty that no harm will result from aggregate exposure 
to the pesticide chemical residue, including all anticipated dietary 
exposures and all other exposures for which there is reliable 
information.'' This includes exposure through drinking water and in 
residential settings, but does not include occupational exposure. 
Section 408(b)(2)(C) of FFDCA requires EPA to give special 
consideration to exposure of infants and children to the pesticide 
chemical residue in establishing a tolerance and to ``ensure that there 
is a reasonable certainty that no harm will result to infants and 
children from aggregate exposure to the pesticide chemical 
    Consistent with section 408(b)(2)(D) of FFDCA, and the factors 
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the 
available scientific data and other relevant information in support of 
this action. EPA has sufficient data to assess the hazards of and to 
make a determination on aggregate exposure for the petitioned-for 
tolerances for residues of cyromazine on bean, succulent at 2.0 ppm. 
EPA's assessment of exposures and risks associated with establishing 
tolerances follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered its 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
children. Cyromazine is not an eye irritant or a dermal sensitizer but 
is a mild skin irritant. The liver and bone marrow (hematological 
system) are the primary targets for oral toxicity for cyromazine based 
on a chronic dog study. Decrease in body weight and food consumption 
are also common effects of cyromazine as observed in chronic dog, rat, 
mouse, and rabbit studies. No dermal or systemic toxicity was seen at 
the highest dose tested in two 21-day dermal toxicity studies in 
rabbits. No neurotoxicity studies with cyromazine are available. 
However, the cyromazine chemical class (triazine) does not generally 
target the central or peripheral nervous system and available data show 
no evidence of neurotoxic potential for cyromazine. There is no 
evidence that cyromazine is teratogenic or that offspring are more 
susceptible than adults based on developmental toxicity studies in rats 
and rabbits. In the 2-generation reproduction study in rats no 
reproductive effects were observed. Cyromazine was shown not to be 
carcinogenic in mice or rats following long-term dietary administration 
and is classified as ``not likely to be carcinogenic to humans.'' The 
available mutagenicity data suggest that cyromazine does not have 
genotoxic activity. Specific information on the studies received and 
the nature of the adverse effects caused by cyromazine as well as the 
no-observed-adverse-effect-level (NOAEL) and the lowest-observed-
adverse-effect-level (LOAEL) from the toxicity studies can be found at 
http://www.regulations.gov in docket ID number EPA-HQ-OPP-2009-0866, 
pages 25-27 of the document titled ``Cyromazine Human Health Risk 
Assessment for Proposed New Use of Cyromazine on Succulent Beans.''

B. Toxicological Endpoints

    For hazards that have a threshold below which there is no 
appreciable risk, a toxicological point of departure (POD) is 
identified as the basis for derivation of reference values for risk 
assessment. The POD may be defined as the highest dose at which no 
adverse effects are observed (the NOAEL) in the toxicology study 
identified as appropriate for use in risk assessment. However, if a 
NOAEL cannot be determined, the lowest dose at which adverse effects of 
concern are identified (the LOAEL) or a Benchmark Dose (BMD) approach 
is sometimes used for risk assessment. Uncertainty/safety factors (UFs) 
are used in conjunction with the POD to take into account uncertainties 
inherent in the extrapolation from laboratory animal data to humans and 
in the variations in sensitivity among members of the human population 
as well as other unknowns. Safety is assessed for acute and chronic 
dietary risks by comparing aggregate food and water exposure to the 
pesticide to the acute population adjusted dose (aPAD) and chronic 
population adjusted dose (cPAD). The

[[Page 22254]]

aPAD and cPAD are calculated by dividing the POD by all applicable UFs. 
Aggregate short-, intermediate-, and chronic-term risks are evaluated 
by comparing food, water, and residential exposure to the POD to ensure 
that the margin of exposure (MOE) called for by the product of all 
applicable UFs is not exceeded. This latter value is referred to as the 
Level of Concern (LOC).
    For non-threshold risks, the Agency assumes that any amount of 
exposure will lead to some degree of risk. Thus, the Agency estimates 
risk in terms of the probability of an occurrence of the adverse effect 
greater than that expected in a lifetime. For more information on the 
general principles EPA uses in risk characterization and a complete 
description of the risk assessment process, see http://www.epa.gov/pesticides/factsheets/riskassess.htm.
    A summary of the toxicological endpoints for cyromazine used for 
human risk assessment can be found at http://www.regulations.gov in 
docket ID number EPA-HQ-OPP-2009-0866, page 15 of the document titled 
``Cyromazine. Human Health Risk Assessment for Proposed New Use of 
Cyromazine on Succulent Beans.''

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary 
exposure to cyromazine, EPA considered exposure under the petitioned-
for tolerances as well as all existing cyromazine tolerances in 40 CFR 
180.414. EPA assessed dietary exposures from cyromazine in food as 
    i. Acute exposure. Quantitative acute dietary exposure and risk 
assessments are performed for a food-use pesticide, if a toxicological 
study has indicated the possibility of an effect of concern occurring 
as a result of a 1-day or single exposure.
    No such effects were identified in the toxicological studies for 
cyromazine; therefore, a quantitative acute dietary exposure assessment 
is unnecessary.
    ii. Chronic exposure. A chronic dietary risk assessments was 
conducted for cyromazine using the Dietary Exposure Evaluation Model 
(DEEM-FCID, Version 2.03), which uses food consumption data from the 
USDA's Continuing Surveys of Food Intakes by Individuals (CSFII) from 
1994-1996 and 1998. As to residue levels in food, tolerance level 
residues and 100% crop treated assumptions were used. DEEM default and 
empirical processing factors were used to modify the tolerance values.
    iii. Cancer. Based on the absence of evidence of carcinogenicity in 
two adequate rodent carcinogenicity studies, EPA has classified 
cyromazine as ``not likely to be carcinogenic to humans.'' Therefore, a 
quantitative exposure assessment to evaluate cancer risk is 
    iv. Anticipated residue and percent crop treated (PCT) information. 
EPA did not use anticipated residue and/or PCT information in the 
dietary assessment for cyromazine. Tolerance level residues and/or 100% 
crop treated were assumed for all food commodities.
    2. Dietary exposure from drinking water. The Agency used screening 
level water exposure models in the dietary exposure analysis and risk 
assessment for cyromazine in drinking water. These simulation models 
take into account data on the physical, chemical, and fate/transport 
characteristics of cyromazine. Further information regarding EPA 
drinking water models used in pesticide exposure assessment can be 
found at http://www.epa.gov/oppefed1/models/water/index.htm. Based on 
the First Index Reservoir Screening Tool (FIRST) and Screening 
Concentration in Ground Water (SCI-GROW) models, the estimated drinking 
water concentrations (EDWCs) of cyromazine for chronic exposures for 
non-cancer assessments are estimated to be 15.8 parts per billion (ppb) 
for surface water and 1.1 ppb for ground water. Modeled estimates of 
drinking water concentrations were directly entered into the dietary 
exposure model. For chronic dietary risk assessment, the water 
concentration of value 15.8 ppb was used to assess the contribution to 
drinking water.
    3. From non-dietary exposure. The term ``residential exposure'' is 
used in this document to refer to non-occupational, non-dietary 
exposure (e.g., for lawn and garden pest control, indoor pest control, 
termiticides, and flea and tick control on pets). Cyromazine is not 
registered for any specific use patterns that would result in 
residential exposure.
    4. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.''
    Cyromazine contains a symmetrical triazine substructure like the 
herbicides simazine and atrazine, but atrazine and simazine are 
chlorotriazines, and the toxicity of these chemicals is associated with 
the presence of a chlorine substituent on the triazine ring. Cyromazine 
is not a chlorotriazine. The chlorotriazines have a much different 
toxicological profile than does cyromazine which does not have a 
chlorine substituent on the triazine ring. EPA has not found cyromazine 
to share a common mechanism of toxicity with any other substances, and 
cyromazine does not appear to produce a toxic metabolite produced by 
other substances. For the purposes of this tolerance action, therefore, 
EPA has assumed that cyromazine does not have a common mechanism of 
toxicity with other substances. For information regarding EPA's efforts 
to determine which chemicals have a common mechanism of toxicity and to 
evaluate the cumulative effects of such chemicals, see EPA's website at 

D. Safety Factor for Infants and Children

    1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA 
shall apply an additional tenfold (10X) margin of safety for infants 
and children in the case of threshold effects to account for prenatal 
and postnatal toxicity and the completeness of the database on toxicity 
and exposure unless EPA determines based on reliable data that a 
different margin of safety will be safe for infants and children. This 
additional margin of safety is commonly referred to as the FQPA SF. In 
applying this provision, EPA either retains the default value of 10X, 
or uses a different additional safety factor when reliable data 
available to EPA support the choice of a different factor.
    2. Prenatal and postnatal sensitivity. Based on the available data, 
there is no quantitative and qualitative evidence of increased 
susceptibility observed following in utero cyromazine exposure to rats 
and rabbits or following prenatal/postnatal exposure in the 2-
generation reproduction study. The database is considered adequate for 
selection of study endpoints and determination of a dose/response to 
characterize the potential prenatal or postnatal toxicity of cyromazine 
to infants and children. No increase in susceptibility was seen in 
developmental toxicity studies in rat and rabbit or reproductive 
toxicity studies in the rat. Toxicity to offspring was observed at dose 
levels the same or greater than those causing maternal or parental 
toxicity. Based on the results of developmental and reproductive 
toxicity studies, there is not a concern for increased qualitative and/
or quantitative susceptibility following in utero exposure to 
    3. Conclusion. EPA has determined that reliable data show the 
safety of

[[Page 22255]]

infants and children would be adequately protected if the FQPA SF were 
reduced to 1X. That decision is based on the following findings:
    i. The toxicity database for cyromazine is complete except for 
acute and subchronic neurotoxicity studies and immunotoxicity testing. 
Recent changes to 40 CFR part 158 make these studies (OPPTS Guideline 
870.7800) required for pesticide registration; however, the available 
data for cyromazine do not show potential for neurotoxicity or 
immunotoxicity. Although specific neurotoxicity studies have not yet 
been submitted, there is no evidence of neurotoxicity in any study in 
the toxicity database for cyromazine. In the absence of specific 
immunotoxicity studies, EPA has evaluated the available cyromazine 
toxicity database to determine whether an additional database 
uncertainty factor is needed to account for potential immunotoxicity. 
No evidence of immunotoxicity was found. Due to the lack of evidence of 
immunotoxicity for cyromazine, EPA does not believe that conducting 
immunotoxicity testing will result in a NOAEL less than the cRfD NOAEL 
of 1.5 mg/kg bw/day already established for cyromazine. Consequently, 
the EPA believes the existing data are sufficient for endpoint 
selection for exposure/risk assessment scenarios and for evaluation of 
the requirements under the FQPA, and an additional database uncertainty 
factor does not need to be applied.
    ii. There is no indication that cyromazine is a neurotoxic chemical 
and there is no need for a developmental neurotoxicity study or 
additional UFs to account for neurotoxicity.
    iii. There is no evidence that cyromazine results in increased 
susceptibility in in utero rats or rabbits in the prenatal 
developmental studies or in young rats in the 2-generation reproduction 
    iv. There are no residual uncertainties identified in the exposure 
databases. The dietary food exposure assessments were performed based 
on 100 PCT and tolerance-level residues. EPA made conservative 
(protective) assumptions in the ground and surface water modeling used 
to assess exposure to cyromazine in drinking water.

E. Aggregate Risks and Determination of Safety

    EPA determines whether acute and chronic pesticide exposures are 
safe by comparing aggregate exposure estimates to the aPAD and cPAD. 
The aPAD and cPAD represent the highest safe exposures, taking into 
account all appropriate SFs. EPA calculates the aPAD and cPAD by 
dividing the POD by all applicable UFs. For linear cancer risks, EPA 
calculates the probability of additional cancer cases given the 
estimated aggregate exposure. Short-, intermediate-, and chronic-term 
risks are evaluated by comparing the estimated aggregate food, water, 
and residential exposure to the POD to ensure that the MOE called for 
by the product of all applicable UFs is not exceeded.
    1. Acute risk. An acute aggregate risk assessment takes into 
account exposure estimates from acute dietary consumption of food and 
drinking water. No adverse effect resulting from a single-oral exposure 
was identified and no acute dietary endpoint was selected. Therefore, 
cyromazine is not expected to pose an acute risk.
    2. Chronic risk. Using the exposure assumptions described in this 
unit for chronic exposure, EPA has concluded that chronic exposure to 
cyromazine from food and water will utilize 85% of the cPAD for 
children 1 to 2 years old, the population group receiving the greatest 
exposure. There are no residential uses for cyromazine.
    3. Short- and intermediate term risk. Short- and intermediate-term 
aggregate exposure takes into account short-term and intermediate-term 
residential exposure plus chronic exposure to food and water 
(considered to be a background exposure level). Cyromazine is not 
registered for any use patterns that would result in residential 
exposure. Therefore, the short-term and intermediate-term aggregate 
risk is the sum of the risk from exposure to cyromazine through food 
and water and will not be greater than the chronic aggregate risk.
    4. Aggregate cancer risk for U.S. population. Cyromazine is 
classified as a ``Group E'' chemical (negative for carcinogenicity in 
humans). This classification is based on the lack of evidence of 
carcinogenicity in mice and rats. EPA does not expect cyromazine to 
pose a cancer risk.
    5. Determination of safety. Based on these risk assessments, EPA 
concludes that there is a reasonable certainty that no harm will result 
to the general population, or to infants and children from aggregate 
exposure to cyromazine residues.

IV. Other Considerations

A. Analytical Enforcement Methodology

    Methods AG-408 [high-performance liquid chromatography/ultraviolet 
(HPLC/UV)] and AG-417A [gas-liquid chromatography/nitrogen-phosphorus 
detector (GLC/NPD)] are the tolerance enforcement methods for 
cyromazine as published in the Pesticide Analytical Manual (PAM), Vol. 
II. These methods combined and with minor modifications comprise Method 
AG-621. The residue data submitted in support of this petition were 
generated using Methods AG-408 and AG-621. Method AG-621 has been 
adequately validated for use for the determination of residues of 
cyromazine in/on bulb vegetables, leafy Brassica vegetables, and turnip 
greens. Method AG-408 is adequate for enforcement of the proposed 
tolerance for residues of cyromazine.

B. International Residue Limits

    There are currently no established Codex maximum residue limits 
(MRLs) for residues of cyromazine on succulent beans.

V. Conclusion

    Therefore, tolerances are established for residues of cyromazine, 
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine, in or on bean, succulent 
at 2.0 ppm.

VI. Statutory and Executive Order Reviews

    This final rule establishes tolerances under section 408(d) of 
FFDCA in response to a petition submitted to the Agency. The Office of 
Management and Budget (OMB) has exempted these types of actions from 
review under Executive Order 12866, entitled Regulatory Planning and 
Review (58 FR 51735, October 4, 1993). Because this final rule has been 
exempted from review under Executive Order 12866, this final rule is 
not subject to Executive Order 13211, entitled Actions Concerning 
Regulations That Significantly Affect Energy Supply, Distribution, or 
Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled 
Protection of Children from Environmental Health Risks and Safety Risks 
(62 FR 19885, April 23, 1997). This final rule does not contain any 
information collections subject to OMB approval under the Paperwork 
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any 
special considerations under Executive Order 12898, entitled Federal 
Actions to Address Environmental Justice in Minority Populations and 
Low-Income Populations (59 FR 7629, February 16, 1994).
    Since tolerances and exemptions that are established on the basis 
of a petition under section 408(d) of FFDCA, such as the tolerance in 
this final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory

[[Page 22256]]

Flexibility Act (RFA) (5 U.S.C. 601 et seq.) do not apply.
    This final rule directly regulates growers, food processors, food 
handlers, and food retailers, not States or tribes, nor does this 
action alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of section 408(n)(4) of FFDCA. As such, the Agency has determined that 
this action will not have a substantial direct effect on States or 
tribal governments, on the relationship between the national government 
and the States or tribal governments, or on the distribution of power 
and responsibilities among the various levels of government or between 
the Federal Government and Indian tribes. Thus, the Agency has 
determined that Executive Order 13132, entitled Federalism (64 FR 
43255, August 10, 1999) and Executive Order 13175, entitled 
Consultation and Coordination with Indian Tribal Governments (65 FR 
67249, November 9, 2000) do not apply to this final rule. In addition, 
this final rule does not impose any enforceable duty or contain any 
unfunded mandate as described under Title II of the Unfunded Mandates 
Reform Act of 1995 (UMRA) (Public Law 104-4).
    This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272 

VII. Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., generally 
provides that before a rule may take effect, the agency promulgating 
the rule must submit a rule report to each House of the Congress and to 
the Comptroller General of the United States. EPA will submit a report 
containing this rule and other required information to the U.S. Senate, 
the U.S. House of Representatives, and the Comptroller General of the 
United States prior to publication of this final rule in the Federal 
Register. This final rule is not a ``major rule'' as defined by 5 
U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: March 26, 2010.
Lois Rossi,
Director, Registration DivisionOffice of Pesticide Programs.

Therefore, 40 CFR chapter I is amended as follows:


1. The authority citation for part 180 continues to read as follows:

    Authority: 21 U.S.C. 321(q), 346a and 371.

2. Section 180.414 is amended by alphabetically adding the following 
commodity to the table in paragraph (a)(1) to read as follows:

Sec. 180.414  Cyromazine; tolerances for residues

    (a)* * * (1)* * *

                   Commodity                        Parts per million
                                * * * * *
Bean, succulent................................                      2.0
                                * * * * *

* * * * *
[FR Doc. 2010-9741 Filed 4-27-10; 8:45 am]